China's securities watchdog instruct lawyers to tone down China-related risk disclosures in prospectuses; new rules restrict export of drones and related technologies; and bubble tea companies seek foreign listings amidst growing regulatory scrutiny
U.S. senators propose amendment to defense bill requiring the tracking of U.S. investments in China; Foreign firms are accelerating their push to decouple their data in China from the rest of the world; and China's commerce minister pledges to open up more opportunities to foreign pharmaceutical firms in a roundtable meeting
The CSRC targets screenshots of texts in Chinese social media containing speculative news affecting share prices; Management fees of mutual funds are decreased to encourage investment activity; and Delistings are reaching record levels as Chinese listing rules tighten.
Edward Tung, legal counsel for Hong Kong-based venture capital firm ORI Capital, discusses his firm's response to U.S. sanctions on Chinese companies, U.S. restrictions targeting foreign companies, artificial intelligence laws in China, and new ESG guidelines.
No Chinese companies have successfully listed overseas due to tight scrutiny from domestic regulators; A Beijing company succeeds in making a SCC filing for the cross-border transfer of data; and China announces measures to open up free trade zones in order to lure back foreign investors.
In the light of important new guidelines to be followed when filing the standard overseas personal information transfer contract, Casper Sek of Jingtian & Gongcheng analyses the key learning points and looks at how companies may apply this in practice
The U.S. government is debating whether to renew the U.S.-China Science and Technology Agreement; AstraZeneca plans to break up its business in China and list it separately in Hong Kong; the Italian government applies Golden Power regulations to limit the influence of China's Sinochem on tyremaker Pirelli
